Primo was published a year ago in JAMA. I’m trying to think of another randomized controlled trial done in pre-dialysis patients looking at metabolic bone disease. I think PRIMO is the only one that looks at an end-point besides PTH. Could that be right?
I must be forgetting one (or a dozen)…
Ooops. Forgot about the proteinuria trials:
